← Back to Clinical Trials
Recruiting NCT06443541

NCT06443541 Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06443541
Status Recruiting
Phase
Sponsor Emory University
Condition Violence, Sexual
Study Type INTERVENTIONAL
Enrollment 3,439 participants
Start Date 2024-03-27
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
High-intensity implementation strategies (HIS)-StudentsLow-intensity implementation strategies (LIS) for StudentsHigh-intensity implementation strategies (HIS) for Faculty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 3,439 participants in total. It began in 2024-03-27 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project, SCALE, will be the first to compare lower-intensity (standard) and higher-intensity implementation strategies to deliver GlobalConsent-an efficacious web-based sexual violence prevention program-to men attending seven universities across Vietnam. Following a rigorous, mixed-methods, comparative interrupted-time-series design, researchers will collect novel data to compare implementation fidelity, drivers and outcomes, effectiveness, and cost-effectiveness across implementation strategy groups. This partnership includes universities also engaged in a violence-prevention training grant (D43TW012188), offering an unparalleled opportunity for capacity strengthening and evidence generation to guide national leaders on the best strategies for launching GlobalConsent at scale, addressing a sex-differentiated risk factor in adolescence, and thereby improving a range of health outcomes into adulthood.

Eligibility Criteria

Inclusion Criteria for Students: * 18 and older * Men who self-identify as heterosexual or bisexual (who are attracted to women), * Enrolled as first-year students in any of the seven participating study universities in North, Central, and South Vietnam. Exclusion Criteria for Students: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) Inclusion Criteria for Faculty: * All registered lecturers at each of the seven participating study universities will be eligible to participate in the faculty surveys in years 1, 4, and 5. Exclusion Criteria for Faculty: * None Inclusion Criteria for Leaders: * Recommendation of study staff at each participating study university * Knowledge about the implementation landscape and implementation of GlobalConsent. Exclusion Criteria for Leaders: * None Inclusion Criteria for Implementation Teams: * Identified by relevant study staff. Exclusion Criteria for Implementation Teams: * None

Contact & Investigator

Central Contact

Kathryn Yount, PhD

✉ kathryn.yount@emory.edu

📞 404-727-8511

Principal Investigator

Kathryn Yount, PhD

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT06443541 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Violence, Sexual. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06443541 currently recruiting?

Yes, NCT06443541 is actively recruiting participants. Contact the research team at kathryn.yount@emory.edu for enrollment information.

Where is the NCT06443541 trial being conducted?

This trial is being conducted at Can Tho, Vietnam, Da Nang, Vietnam, Haiphong, Vietnam, Hanoi, Vietnam and 3 additional locations.

Who is sponsoring the NCT06443541 clinical trial?

NCT06443541 is sponsored by Emory University. The principal investigator is Kathryn Yount, PhD at Emory University. The trial plans to enroll 3,439 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology